Tandem Diabetes Care TNDM Cash Flow Statement
| Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | ||
|---|---|---|---|---|---|---|
| -$20.39M-3,362% | -$589K+97.2% | -$21.17M+59.6% | -$52.4M+59.9% | -$130.56M— | ||
| $4.5M+0.2% | $4.5M0.0% | $4.49M+2.9% | $4.37M+1.3% | $4.31M+1.6% | ||
| $15.66M-22.1% | $20.11M-4.9% | $21.14M-17.6% | $25.64M+0.6% | $25.49M-9.5% | ||
| $576K+29.1% | $446K+0.5% | $444K-4.5% | $465K-7.9% | $505K+0.6% | ||
| $2.11M-22.8% | $2.73M-13.8% | $3.17M+47.7% | $2.15M+50.0% | $1.43M-46.5% | ||
| -$22.68M-154% | $42.01M+3,177% | $1.28M-52.0% | $2.67M-75.3% | $10.84M-10.3% | ||
| -$1.93M+74.5% | -$7.56M-45.6% | -$5.19M-111% | -$2.46M+74.4% | -$9.6M-1,514% | ||
| $13.75M+136% | $5.82M+162% | -$9.33M— | —— | $6.64M+561% | ||
| -$14.74M-1,612% | -$861K-107% | $12.85M— | —— | -$13.71M— | ||
| $8.52M-18.6% | $10.47M+17,269% | -$61K+97.8% | -$2.81M-291% | -$718K-58.5% | ||
| $762K— | —— | $226K-94.6% | $4.21M+553% | $644K+1.6% | ||
| $1.8M-45.7% | $3.32M+438% | $617K— | —— | $2.05M+178% | ||
| -$1.08M-57.1% | -$686K+50.7% | -$1.39M-25.0% | -$1.11M+30.2% | -$1.6M+94.9% | ||
| -$3.87M+15.1% | -$4.55M-67.1% | -$2.72M+19.3% | -$3.38M+4.7% | -$3.54M-72.5% | ||
| $7.89M-22.7% | $10.21M+1,563% | $614K-82.0% | $3.41M-31.9% | $5M-53.3% | ||
| $11.05M— | —— | —— | -$9.5M+48.0% | -$18.28M-271% | ||
| $6.27M-6.2% | $6.69M+63.4% | $4.09M-34.1% | $6.21M+109% | $2.97M-3.4% | ||
| $216.13M+629% | $29.66M+0.5% | $29.51M+73.1% | $17.05M+80.4% | $9.45M-27.0% | ||
| $26.95M-52.3% | $56.49M+4.3% | $54.14M-33.5% | $81.38M+25.1% | $65.07M-3.5% | ||
| $0— | $0— | $0— | $0-100% | $75.22M— | ||
| -$195.45M— | —— | $20.54M-64.7% | $58.13M+533% | $9.19M— | ||
| $291.16M— | $0— | $0— | $0— | $0— | ||
| $274.16M— | $0+100% | -$1.57M+96.0% | -$39.71M-747% | -$4.69M-304% | ||
| -$1.08M-185% | $1.27M+110% | $605K-62.6% | $1.62M+186% | -$1.88M-187% | ||
| $88.69M— | —— | $27.84M— | —— | -$15.66M-178% | ||
| —— | $117K+149% | $47K-98.6% | $3.33M+114% | $1.56M-13.4% | ||
| $576K+29.1% | $446K+0.5% | $444K-4.5% | $465K-7.9% | $505K+0.6% | ||
| -$3.87M+15.1% | -$4.55M-67.1% | -$2.72M+19.3% | -$3.38M+4.7% | -$3.54M-72.5% | ||
| -$14.74M-354% | $5.8M-54.9% | $12.85M+1,113% | $1.06M+108% | -$13.71M-347% | ||
| $7.89M-22.7% | $10.21M+1,563% | $614K-82.0% | $3.41M-31.9% | $5M-53.3% | ||
| $762K— | —— | $226K-94.6% | $4.21M+553% | $644K+1.6% | ||
| $19M— | —— | $9.79M+11,557% | $84K-96.3% | $2.26M+5.9% | ||
| $747K-57.2% | $1.75M+476% | $303K-52.1% | $632K-44.9% | $1.15M-33.5% | ||
| $0— | —— | —— | —— | $6.7M— | ||
| $2.11M-22.8% | $2.73M-13.8% | $3.17M+47.7% | $2.15M+50.0% | $1.43M-46.5% | ||
| $0— | $0— | $0— | $0-100% | $75.22M— | ||
| $0-100% | $35.12M— | —— | —— | $43.46M— | ||
| $216.13M+629% | $29.66M+0.5% | $29.51M+73.1% | $17.05M+80.4% | $9.45M-27.0% | ||
| $26.95M-52.3% | $56.49M+4.3% | $54.14M-33.5% | $81.38M+25.1% | $65.07M-3.5% | ||
| $1.7M— | —— | —— | —— | $4.69M+179% | ||
| $15.3M— | $0— | $0— | $0— | $0— | ||
| $842K-70.7% | $2.87M— | —— | —— | $4.2M— | ||
| -$1.08M-57.1% | -$686K+50.7% | -$1.39M-25.0% | -$1.11M+30.2% | -$1.6M+94.9% | ||
| $7.89M-22.7% | $10.21M+1,563% | $614K-82.0% | $3.41M-31.9% | $5M-53.3% | ||
| $13.3M— | —— | —— | $13.3M— | $0— | ||
| $1.85M— | $0-100% | $26.17M+1,538% | -$1.82M-200% | $1.82M— | ||
| $290K— | —— | —— | —— | —— | ||
| $4.79M— | —— | —— | -$15.7M+26.1% | -$21.24M-378% | ||
| $4.79M— | —— | —— | -$15.7M+26.1% | -$21.24M-378% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- How much cash does Tandem Diabetes Care generate?
- Tandem Diabetes Care (TNDM) generated -$6.0M in operating cash flow over the trailing twelve months.
- What is Tandem Diabetes Care's free cash flow?
- After $23.3M of capital expenditures, Tandem Diabetes Care's free cash flow was -$24.5M over the trailing twelve months, down 62.7% year over year.
- Where does Tandem Diabetes Care's cash flow data come from?
- Every line is extracted from Tandem Diabetes Care's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
